Originally published In Press as doi:10.1074/mcp.M700312-MCP200 on October 22, 2007.
Molecular & Cellular Proteomics 7:768-784, 2008.
© 2008 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Defining the Specificity Space of the Human Src Homology 2 Domain*,S
Haiming Huang , ,
Lei Li , ,
Chenggang Wu , ,
David Schibli ,
Karen Colwill¶,
Sucan Ma||,
Chengjun Li ,
Protiva Roy ,
Krystina Ho ,
Zhou Songyang**,
Tony Pawson¶,
Youhe Gao|| and
Shawn S.-C. Li ,
From the Department of Biochemistry and the Siebens-Drake Medical Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 5C1, Canada, ¶ Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto M5G 1X8, Canada, || Proteomics Research Center, National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/Peking Union Medical College, 100005 Beijing, China, and ** Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030
Src homology 2 (SH2) domains are the largest family of interaction modules encoded by the human genome to recognize tyrosine-phosphorylated sequences and thereby play pivotal roles in transducing and controlling cellular signals emanating from protein-tyrosine kinases. Different SH2 domains select for distinct phosphopeptides, and the function of a given SH2 domain is often dictated by the specific motifs that it recognizes. Therefore, deciphering the phosphotyrosyl peptide motif recognized by an SH2 domain is the key to understanding its cellular function. Here we cloned all 120 SH2 domains identified in the human genome and determined the phosphotyrosyl peptide binding properties of 76 SH2 domains by screening an oriented peptide array library. Of these 76, we defined the selectivity for 43 SH2 domains and refined the binding motifs for another 33 SH2 domains. We identified a number of novel binding motifs, which are exemplified by the BRDG1 SH2 domain that selects specifically for a bulky, hydrophobic residue at P + 4 relative to the Tyr(P) residue. Based on the oriented peptide array library data, we developed scoring matrix-assisted ligand identification (or SMALI), a Web-based program for predicting binding partners for SH2-containing proteins. When applied to SH2D1A/SAP (SLAM-associated protein), a protein whose mutation or deletion underlies the X-linked lymphoproliferative syndrome, SMALI not only recapitulated known interactions but also identified a number of novel interacting proteins for this disease-associated protein. SMALI also identified a number of potential interactors for BRDG1, a protein whose function is largely unknown. Peptide in-solution binding analysis demonstrated that a SMALI score correlates well with the binding energy of a peptide to a given SH2 domain. The definition of the specificity space of the human SH2 domain provides both the necessary molecular basis and a platform for future exploration of the functions for SH2-containing proteins in cells.
 Holds a Canada Research Chair in Functional Genomics and Cellular Proteomics. To whom correspondence should be addressed. E-mail: sli{at}uwo.ca

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Sulahian, O. Cleaver, and L. J.-s. Huang
Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia
Blood,
May 21, 2009;
113(21):
5287 - 5297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-E. Huot, C. M. Brown, N. Lamarche-Vane, and S. Richard
An Adaptor Role for Cytoplasmic Sam68 in Modulating Src Activity during Cell Polarization
Mol. Cell. Biol.,
April 1, 2009;
29(7):
1933 - 1943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hanke and M. Mann
The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
Mol. Cell. Proteomics,
March 1, 2009;
8(3):
519 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. McPherson, S. Everingham, R. Karisch, J. A. Smith, C. M. Udell, J. Zheng, Z. Jia, and A. W. B. Craig
Contributions of F-BAR and SH2 Domains of Fes Protein Tyrosine Kinase for Coupling to the Fc{varepsilon}RI Pathway in Mast Cells
Mol. Cell. Biol.,
January 15, 2009;
29(2):
389 - 401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zoubeidi, J. Rocha, F. Z. Zouanat, L. Hamel, E. Scarlata, A. G. Aprikian, and S. Chevalier
The Fer Tyrosine Kinase Cooperates with Interleukin-6 to Activate Signal Transducer and Activator of Transcription 3 and Promote Human Prostate Cancer Cell Growth
Mol. Cancer Res.,
January 1, 2009;
7(1):
142 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Miller, L. J. Jensen, F. Diella, C. Jorgensen, M. Tinti, L. Li, M. Hsiung, S. A. Parker, J. Bordeaux, T. Sicheritz-Ponten, et al.
Linear Motif Atlas for Phosphorylation-Dependent Signaling
Sci. Signal.,
September 2, 2008;
1(35):
ra2 - ra2.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|